Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6871.20 | 1445 / 1445 | 100% | 88.41 | 183 / 183 |
pancreas | 100% | 5243.59 | 328 / 328 | 100% | 72.01 | 178 / 178 |
lung | 100% | 6856.47 | 578 / 578 | 100% | 92.57 | 1154 / 1155 |
intestine | 100% | 6897.62 | 966 / 966 | 100% | 98.37 | 526 / 527 |
ovary | 100% | 8794.72 | 180 / 180 | 100% | 66.85 | 429 / 430 |
stomach | 100% | 5878.45 | 359 / 359 | 100% | 86.17 | 285 / 286 |
bladder | 100% | 7227.14 | 21 / 21 | 100% | 101.13 | 502 / 504 |
uterus | 100% | 8719.44 | 170 / 170 | 100% | 113.69 | 457 / 459 |
breast | 100% | 7197.43 | 459 / 459 | 100% | 97.13 | 1113 / 1118 |
prostate | 100% | 6248.47 | 245 / 245 | 99% | 72.74 | 499 / 502 |
skin | 100% | 9804.34 | 1809 / 1809 | 99% | 104.80 | 469 / 472 |
brain | 99% | 4227.83 | 2625 / 2642 | 100% | 94.46 | 705 / 705 |
thymus | 100% | 7550.06 | 653 / 653 | 99% | 79.02 | 601 / 605 |
kidney | 100% | 4959.15 | 89 / 89 | 97% | 54.45 | 875 / 901 |
liver | 99% | 2843.92 | 224 / 226 | 96% | 40.54 | 388 / 406 |
adrenal gland | 100% | 5231.24 | 258 / 258 | 93% | 46.32 | 213 / 230 |
adipose | 100% | 6691.80 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 113.44 | 29 / 29 |
muscle | 100% | 7616.14 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6713.76 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 118.67 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 46.29 | 1 / 1 |
blood vessel | 100% | 5501.96 | 1334 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 73.08 | 79 / 80 |
heart | 98% | 3165.90 | 843 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 79% | 5042.21 | 738 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006281 | Biological process | DNA repair |
GO_0006337 | Biological process | nucleosome disassembly |
GO_1902275 | Biological process | regulation of chromatin organization |
GO_0006260 | Biological process | DNA replication |
GO_0006334 | Biological process | nucleosome assembly |
GO_0005730 | Cellular component | nucleolus |
GO_0035101 | Cellular component | FACT complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0031491 | Molecular function | nucleosome binding |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0042393 | Molecular function | histone binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | SSRP1 |
Protein name | Alternative protein SSRP1 FACT complex subunit SSRP1 Structure specific recognition protein 1 FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit) (FACT 80 kDa subunit) (FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (hSSRP1) (T160) |
Synonyms | FACT80 |
Description | FUNCTION: Component of the FACT complex, a general chromatin factor that acts to reorganize nucleosomes. The FACT complex is involved in multiple processes that require DNA as a template such as mRNA elongation, DNA replication and DNA repair. During transcription elongation the FACT complex acts as a histone chaperone that both destabilizes and restores nucleosomal structure. It facilitates the passage of RNA polymerase II and transcription by promoting the dissociation of one histone H2A-H2B dimer from the nucleosome, then subsequently promotes the reestablishment of the nucleosome following the passage of RNA polymerase II. The FACT complex is probably also involved in phosphorylation of 'Ser-392' of p53/TP53 via its association with CK2 (casein kinase II). Binds specifically to double-stranded DNA and at low levels to DNA modified by the antitumor agent cisplatin. May potentiate cisplatin-induced cell death by blocking replication and repair of modified DNA. Also acts as a transcriptional coactivator for p63/TP63. . FUNCTION: Component of the FACT complex, a general chromatin factor that acts to reorganize nucleosomes. The FACT complex is involved in multiple processes that require DNA as a template such as mRNA elongation, DNA replication and DNA repair. During transcription elongation the FACT complex acts as a histone chaperone that both destabilizes and restores nucleosomal structure. It facilitates the passage of RNA polymerase II and transcription by promoting the dissociation of one histone H2A-H2B dimer from the nucleosome, then subsequently promotes the reestablishment of the nucleosome following the passage of RNA polymerase II. . |
Accessions | Q08945 ENST00000529002.2 A0A0U1RRK2 L8EA29 ENST00000635721.1 ENST00000526696.6 E9PMD4 E9PPZ7 ENST00000278412.7 |